Cytek Biosciences Inc (NAS:CTKB)
$ 3.13 -0.17 (-5.15%) Market Cap: 396.44 Mil Enterprise Value: 146.73 Mil PE Ratio: 0 PB Ratio: 1.05 GF Score: 70/100

Q3 2021 Cytek Biosciences Inc Earnings Call Transcript

Nov 8, 2021 / 09:30 PM GMT
Release Date Price: $25.04 (+1.34%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CTKB.OQ - Cytek Biosciences Inc
Q3 2021 Cytek Biosciences Inc Earnings Call
Nov 08, 2021 / 09:30PM GMT

=====================
Conference Call Participants
=====================
* Alexandra Khan
Gilmartin Group LLC - IR
* Wenbin Jiang
Cytek Biosciences, Inc. - CEO & Chairman
* Patrik Jeanmonod
Cytek Biosciences, Inc. - CFO
* Max Masucci
Cowen and Company - Analyst
* David Delahunt
Goldman Sachs - Analyst

=====================
Presentation
--------------------------------------------------------------------------------
Operator [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by and welcome to Cytek Biosciences' third-quarter 2021 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your host today, Alexander Khan, Investor Relations. Please
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot